CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – France”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in France. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of France. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2010, the French pharmaceutical market was worth $36.5B, which decreased to an estimated $33.5B in 2017 at a negative Compound Annual Growth Rate (CAGR) of 1.5%. The French medical devices market was valued at $17.7B in 2015, which increased to $19B in 2017. The market is expected to grow at a CAGR of 4% from $19.7B in 2018 to $21.2B in 2020. Regulatory reforms have led to faster and more efficient drug approval processes. The French healthcare system provides universal health coverage, healthcare reimbursement, and open healthcare access with implementation of E-health card for the French people.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the France, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Sanofi, Servier, Pierre Fabre and Ipsen) and profiles and SWOT analyses of the major players in the medical device market (Roche, Medtronic, Abbott, Siemens and Boston Scientific)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of France
  • Porter’s five forces analysis for pharmaceutical and medical devices market of France
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the French healthcare market

Reasons to buy

The report provides information on the healthcare, regulatory, and reimbursement landscape in the France, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Sanofi, Servier, Pierre Fabre and Ipsen) and profiles and SWOT analyses of the major players in the medical device market (Roche, Medtronic, Abbott, Siemens and Boston Scientific)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of France
  • Porter’s five forces analysis for pharmaceutical and medical devices market of France
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the French healthcare market

Table of Contents

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary – Overview

2.2 Key ...

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary – Overview

2.2 Key Highlights

2.3 Key Events: French Pharmaceutical History, 2011–2019

2.4 Key Facts: French Pharmaceutical Market

2.5 Impact of Brexit on French Healthcare System

2.6 Key Events: M&A, VF & PE Deals, Global Pharmaceutical Market, 2017–2018

2.7 Key Events: Mergers and Acquisitions

2.8 Country Profile, France, 2018

3 Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Market Segments

3.5 Pharmaceutical Market – Top Five Disease Areas

3.6 Pharmaceutical Market – Supply Channels

3.7 Pharmaceutical Market – Major Players

4 Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Device Market – Top Five Segments

4.3 Medical Device Market – Diagnostic Market

4.4 Medical Device Market – Major Players

5 Pharmaceutical and Medical Device Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6 Deal analysis

6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, France

6.2 Deal Analysis: M&A, VF and PE Deals, Medical Device Market, France

7 Pharmaceutical and Medical Device Market – Porter’s Five Forces Analysis

7.1 Pharmaceutical Market, France – Porter’s Five Forces Analysis

7.2 Medical Device Market, France – Porter’s Five Forces Analysis

8 Market Access

8.1 Overview of Healthcare System, France

8.2 Reimbursement Process, France

8.2.1 Overview of Insurance Providers (Public), France

8.2.2 Overview of Insurance Providers (Private), France

8.2.3 Healthcare Spending and Consumer Price Index, France

8.2.4 Pricing Policies, France

8.3 Regulatory Landscape, France

8.3.1 Market Authorization for Pharmaceutical Products, France

8.3.2 Market Authorization for Medical Devices, France

8.3.3 Exports and Imports, France

8.3.4 Intellectual Property Rights, Patent, France

8.3.5 Intellectual Property Rights, Trademark, France

8.3.6 Clinical Trial Regulation Process, France

8.3.7 Pharmaceutical Advertising Regulations, France

8.3.8 Labeling and Packaging Regulations, France

9 Country Healthcare Landscape

9.1 Healthcare Policy Highlights

9.2 Healthcare Facilities

9.3 Healthcare Parameters

9.4 Environmental Health

9.5 Healthcare Personnel

9.6 Disease Burden

9.7 Healthcare Expenditure

9.7.1 Healthcare Expenditure – Overview

9.7.2 Share of Public and Private Sectors

9.7.3 Major Components of Healthcare Expenditure

10 Trade Associations

11 Trade Fairs, France

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.1.4 Expert Panel

13.2 Bibliography

13.3 Contact Us

13.4 Disclaimer

List of Tables

Table 1: Pharmaceutical Market, France, Sales of Patented Drug Products by Major Therapeutic Class at Ex factory Prices (%), 2017

Table 2: Medical Device Market, France ...

Table 1: Pharmaceutical Market, France, Sales of Patented Drug Products by Major Therapeutic Class at Ex factory Prices (%), 2017

Table 2: Medical Device Market, France, Revenue by Segment ($B), 2017

Table 3: IVD Market, France, Revenue ($M) and Market Share (%) of Major Companies

Table 4: Cardiovascular Devices , France, Revenue ($M) and Market Share (%) of Major Companies

Table 5: Hospital Supplies Market, France, Revenue ($M) and Market Share (%) of Major Companies

Table 6: Orthopedic Devices Market, France, Revenue ($M) and Market Share (%) of Major Companies

Table 7: Ophthalmic Devices Market, France, Revenue ($M) and Market Share (%) of Major Companies

Table 8: Actual Clinical Benefit (ACB), France, 2018

Table 9: Clinical Added Value (CAV), France, 2018

Table 10: Rreimbursement Rates for Medical Procedures and Services Covered by Health Insurance Schemes, France, 2019

Table 11: Pricing Based on ASMR Level, France, 2018

Table 12: Patent Fees, France, 2018

Table 13: Trademark Fees, France, 2018

Table 14: Label of a Pharmaceutical Product, France, 2017

Table 15: Minimum particulars to appear on blisters or strips , France, 2017

Table 16: Minimum particulars to appear on small immediate packaging , France, 2017

List of Figures

Figure 1: Pharmaceutical Market, France, Revenue ($B), 2010–2017

Figure 2: Medical Device Market, France, Revenue ($B), 2015–2020

Figure 3: Number of Deals (2018 ...

Figure 1: Pharmaceutical Market, France, Revenue ($B), 2010–2017

Figure 2: Medical Device Market, France, Revenue ($B), 2015–2020

Figure 3: Number of Deals (2018–2019)

Figure 4: 2018-19 Deal Overview By Region

Figure 5: Country Profile, France, 2018

Figure 6: Pharmaceutical Market, France, Revenue ($B), 2010–2017

Figure 7: Pharmaceutical Market, France, Revenue Forecast ($B), 2018–2022

Figure 8: Pharmaceutical Market, France, Pharmaceutical Exports

Figure 9: Pharmaceutical Market, France, Top Export Partners

Figure 10: Pharmaceutical Market, France, Pharmaceutical Imports

Figure 11: Pharmaceutical Market, France, Top Import Partners

Figure 12: Marketing Authorizations for Generic Medicines, France, 2012–2017

Figure 13: Availability of Biologics in Healthcare Settings, France, 2017

Figure 14: Competitiveness Clusters , France, 2017

Figure 15: Government Funded Biosimilars, France, 2017

Figure 16: Pharmaceutical OTC Market, France, Revenue ($B), 2010–2017

Figure 17: Major OTC Drug Classes (Share%), France, 2017

Figure 18: Pharmaceutical Market, France, Supply Channels

Figure 19: Pharmaceutical Market, France, Sales of Patented Drug Products by Major Therapeutic Class at Ex factory Prices (%), 2017

Figure 20: Pharmaceutical Market, Major Players, France

Figure 21: Medical Device Market, France, Revenue ($B), 2015–2020

Figure 22: Medical Device Market, France, Revenue Forecast ($B), 2021–2025

Figure 23: Medical Device Market, France, Revenue by Segment ($B), 2018

Figure 24: IVD Market, France, Revenue ($B), 2015–2022

Figure 25: IVD Market, France, Market Share of Major Players (%)

Figure 26: Cardiovascular Devices Market, France, Revenue ($B), 2015–2022

Figure 27: Cardiovascular Devices Market, France, Market Share of Major Players (%)

Figure 28: Hospital Supplies, France, Revenue ($B), 2015–2022

Figure 29: Hospital Supplies, France, Market Share of Major Players (%)

Figure 30: Orthopedic Market, France, Revenue ($B), 2015–2022

Figure 31: Orthopedic Devices Market, France, Market Share of Major Players (%)

Figure 32: Ophthalmic Devices Market, France, Revenue ($B), 2015–2022

Figure 33: Ophthalmic Devices Market, France, Market Share of Major Players (%)

Figure 34: Diagnostic Market, France, Revenue ($B), 2015–2018

Figure 35:Diagnostic Market, France, Revenue Forecast ($B), 2019–2022

Figure 36: Medical Device Market – Major Players

Figure 37: Deal Value and Deal Count, Pharmaceutical Market,

France, 2018–2019

Figure 38: Deal Value and Deal Count Quarterly, Pharmaceutical Market,

France, 2018–2019

Figure 39: Deal Value and Deal Count Sub-Types, Pharmaceutical Market,

France, 2018–2019

Figure 40: Top Five Therapy Areas by Deal Value, Pharmaceutical Market,

France, 2018–2019

Figure 41: Top Five Therapy Areas by Deal Number, Pharmaceutical Market,

France, 2018–2019

Figure 42: M&A Deals by Therapy Area, Pharmaceutical Market,

France, 2018–2019(by value and by number)

Figure 43: Venture Financing Deals by Therapy Area, Pharmaceutical Market

France, 2018–2019(by value and by number)

Figure 44: Private Equity Deals by Therapy Area, Pharmaceutical Market

France, 2018–2019(by value and by number)

Figure 45: Medical Device Market Deals, France, 2018–2019(by deal value, $M)

Figure 46: Medical Device Market Deals, France, 2018 –2019(by deal count)

Figure 47: Medical Device Market Deals Share (by deal count), France, 2018 – 2019

Figure 48: Medical Device Market Deals Share (by deal value), France, 2018 – 2019

Figure 49: Top Five Therapy Areas by Deal Value, Medical Device,

France, 2018–2019

Figure 50: Top Five Therapy Areas by Deal Number, Medical Device,

France, 2018–2019

Figure 51: M&A Deals by Therapy Area, Medical Device,

France, 2018–2019 (by number)

Figure 52: Venture Financing Deals by Therapy Area, Medical Device, France, 2018–2019(by value and by number)

Figure 53: Private Equity Deals by Therapy Area, Medical Device

France, 2018–2019(By number)

Figure 54: Healthcare System, France, 2018

Figure 55: Workflow of Healthcare System, France, 2018

Figure 56: Medicine Assessment Process, France, 2018

Figure 57: Medical Device Assessment Process, France, 2018

Figure 58: Network of Public Insurance Providers, France, 2018

Figure 59: Revenue Structure of CNAM, France, 2017

Figure 60: Funding by Mutuals, France, 2018

Figure 61: Funding by Provident Institutions, France, 2018

Figure 62: Funding by Insurance Companies, France, 2018

Figure 63: OOP Expenditure (% of total expenditure on health), France, 2010–2016

Figure 64: Annual Rate of Change (%), Health Price Index, France, 2010–2019

Figure 65: Pricing Process, France, 2019

Figure 66: The Evolution of the Price of Drugs, France, 2018

Figure 67: ANSM, Organizational Structure, France, 2019

Figure 68: National Procedure, France, 2017

Figure 69: Centralized Procedure, 2018

Figure 70: Decentralized Procedure, 2018

Figure 71: Mutual Recognition Procedure, 2018

Figure 72: Conformity Assessment of Class I Medical Devices, EU, 2018

Figure 73: Conformity Assessment of Class IIa Medical Devices, EU, 2018

Figure 74: Conformity Assessment of Class IIb Medical Devices, EU, 2018

Figure 75: Conformity Assessment of Class III Medical Devices, EU, 2018

Figure 76: European Patent Approval Process EU, 2017

Figure 77: Unitary Patent Approval Process EU, 2017

Figure 78: Clinical Trial Approval Process, France, 2017

Figure 79: Number of Hospitals, France, 2010–2017

Figure 80: Diagnostic Equipment

(per Million Population), France, 2010–2017

Figure 81: Hospital Beds (per 1,000 population), France

Figure 82: Acute Care Hospital Beds (per 1,000 population), France

Figure 83: Psychiatric Hospital Beds (per 1,000 population), France

Figure 84: Life Expectancy (Years), 2010–2016, France

Figure 85: Immunization Rate (%), France, 2010–2017

Figure 86: PM2.5 (µg per m3), France, 2010–2016

Figure 87: CO2 Emissions (million tons), France, 2010–2017

Figure 88: Physicians (per 1,000 population), France, 2009–2017

Figure 89: Dentists (per 1,000 population), France, 2010–2017

Figure 90: Nurses (per 1,000 population), France, 2010–2017

Figure 91: Pharmacists (per 1,000 population), France, 2010–2017

Figure 92:Major Causes of Mortality (number of deaths), France, 2016

Figure 93: Major Causes of Male Mortality (number of deaths), France, 2016

Figure 94: Major Causes of Female Mortality (number of deaths), France, 2016

Figure 95:Disability-Adjusted Life Years by Major Disease (millions), France, 2016

Figure 96:Healthcare Expenditure as Percentage of GDP (%), France,

2009–2017

Figure 97: Public-Private Share (%), France, 2010–2017

Figure 98: Major Components of Healthcare Expenditure (%), France, 2017

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports

We liked the fact the analysts really wanted to engage and think about the issues, were willing to spend 10-15 minutes on the phone talking with us

  DRI Capital